Table 3.
Reference | No. of cCRs | % | Mean Interval to LR (months) | No. of Patients | OS |
DFS |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
NOM |
Operative Arm |
NOM |
Operative Arm |
|||||||||
Survival | % | Survival | % | Survival | % | Survival | % | |||||
Habr-Gama et al125 | 71 | 27 | 60 | 2 | 5-year | 100 | 5-year | 88 | 5-year | 92 | 5-year | 83 |
Habr-Gama et al126 | 90 | 49 | 17 | 28 | 5-year | 91 | N.A. | 5-year | 68 | N.A. | ||
Maas et al127 | 21 | 11 | 22 | 1 | 2-year | 100 | 2-year | 91 | 2-year | 89 | 2-year | 93 |
Smith et al128 | 32 | N.A. | 11 | 6 | 2-year | 97 | 2-year | 88 | 2-year | 100 | 2-year | 98 |
Abbreviations: cCR, clinical complete response; CRT, chemoradiotherapy; DFS, disease-free survival; LARC, locally advanced rectal cancer; LR, local recurrence; N.A., not available; NOM, nonoperative management; OS, overall survival; RT, radiotherapy;